NCT01267058View on ClinicalTrials.gov

Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

February 28, 1998

Study Completion Date

February 28, 1998

Conditions
DiphtheriaPertussisTetanus
Interventions
BIOLOGICAL

GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine

Intramuscular, single dose

BIOLOGICAL

GSK Biologicals' acellular pertussis vaccine

Intramuscular, single dose

BIOLOGICAL

Commonwealth Serum Laboratories' combined diphtheria and tetanus vaccine

Intramuscular, single dose

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY